Protein Study of Rhabdomyosarcoma in Young People
Part of Cancer clinical trials.
This study uses a special machine to find unique protein patterns in rhabdomyosarcoma tumor samples from children and young adults. By analyzing leftover tissue from past biopsies or surgeries, researchers hope to better understand the disease and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with rhabdomyosarcoma between the ages of 0 and 25.
- Your diagnosis was confirmed by a biopsy or surgical sample (tissue).
- You received your care at the Oscar Lambret Center in Lille, France, between 2005 and 2024.
- A piece of your tumor, stored in a wax block (FFPE), is available for testing.
- You are not under a legal guardianship or trusteeship.
- You do not object to researchers using your leftover tumor tissue and medical records for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different treatment plans for children with rhabdomyosarcoma based on their individual risk factors. It aims to find the best therapy for each child, potentially improving outcomes.
This trial compares two different chemotherapy schedules for children and young adults with intermediate-risk rhabdomyosarcoma (a type of muscle cancer). One group gets a higher dose of chemotherapy over a shorter period, while the other gets a lower dose plus maintenance therapy for a longer time. The goal is to see which approach works better.
This early-phase trial tests a new immune cell therapy (CAR T cells) for children and young adults whose rhabdomyosarcoma has returned or not responded to standard treatments. The goal is to see if these specially engineered cells can find and attack the cancer.
This trial tests a personalized mRNA vaccine for people with rhabdomyosarcoma that hasn't responded to other treatments. The vaccine is designed to help your immune system fight the cancer.
This study looks at what makes people with rhabdomyosarcoma join or stay in clinical trials. It is an observational study, not a treatment test.
This study tests different treatment approaches for rhabdomyosarcoma (RMS) in children and adults, including newly diagnosed high-risk cases, people needing radiotherapy, and people whose RMS has returned. It’s designed to find safer dosing and more effective therapy while checking whether participants can proceed based on health and timing requirements.
Hear when a new Rhabdomyosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.